Inventor · disambiguated record
Bernard Bourrie
Also filed as: BOURRIE BERNARD
30 granted patents·2 pending applications·175 citations·filing 1985–2014
96Inventor score
Top patents by PatentIndex Score
32 records- 0194US6482986B1Benzene derivatives, preparation method and pharmaceutical compositions containing sameSANOFI SYNTHELABO·Filed 2000·Granted Nov 19, 2002·49 cites·15 claims
- 0291US6642258B1Use of central cannabinoid receptor antagonist for preparing medicinesSANOFI SYNTHELABO·Filed 2000·Granted Nov 4, 2003·39 cites·16 claims
- 0384US7504406B2Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the sameSANOFI AVENTIS·Filed 2007·Granted Mar 17, 2009·6 cites·6 claims
- 0483US7390818B2Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeuticsSANOFI AVENTIS·Filed 2005·Granted Jun 24, 2008·4 cites·10 claims
- 0581US6967203B2Use of pyridoindolone derivatives for preparing anticancer medicinesSANOFI AVENTIS·Filed 2002·Granted Nov 22, 2005·12 cites·10 claims
- 0677US8008310B2Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the sameSANOFI AVENTIS·Filed 2009·Granted Aug 30, 2011·2 cites·9 claims
- 0777US7893259B2Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereofSANOFI AVENTIS·Filed 2009·Granted Feb 22, 2011·2 cites·8 claims
- 0877US6689797B2Tetrahydropyridines, preparation method and pharmaceutical compositions containing sameSANOFI SYNTHELABO·Filed 2000·Granted Feb 10, 2004·10 cites·22 claims
- 0976US7544682B2Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereofSANOFI AVENTIS·Filed 2007·Granted Jun 9, 2009·2 cites·17 claims
- 1074US7186720B2Tetrahydropyridyl-alkyl-heterocycles, method for preparing the same and pharmaceutical compositions containing the sameSANOFI AVENTIS·Filed 2002·Granted Mar 6, 2007·7 cites·20 claims
- 1168US7842806B2Pyridopyrimidone derivatives, preparation thereof, therapeutic use thereofSANOFI AVENTIS·Filed 2008·Granted Nov 30, 2010·1 cites·22 claims
- 1268US6509351B1Phenyl- and pyridyl-tetrahydro-pyridines having TNF inhibiting activitySANOFI SYNTELABO·Filed 2000·Granted Jan 21, 2003·6 cites·31 claims
- 1365US7160895B2Use of pyridoindolone derivatives for the preparation of medicinal productsSANOFI AVENTIS·Filed 2005·Granted Jan 9, 2007·0 cites·10 claims
- 1465US4749566APharmaceutical composition comprising a combination of at least one immunotoxin and at least one mannose-containing polymerSANOFI SA·Filed 1985·Granted Jun 7, 1988·11 cites·10 claims
- 1563US7326723B2Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing sameSANOFI AVENTIS·Filed 2002·Granted Feb 5, 2008·1 cites·20 claims
- 1661US7858824B2Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing themSANOFI AVENTIS·Filed 2007·Granted Dec 28, 2010·0 cites·2 claims
- 1760US7816368B2Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeuticsSANOFI AVENTIS·Filed 2008·Granted Oct 19, 2010·0 cites·7 claims
- 1858US8012991B2Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeuticsSANOFI AVENTIS·Filed 2008·Granted Sep 6, 2011·0 cites·7 claims
- 1954US6344464B1Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelinationSANOFI SYNTHELABO·Filed 1998·Granted Feb 5, 2002·11 cites·29 claims
- 2053US7456193B2Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeuticsSANOFI AVENTIS·Filed 2005·Granted Nov 25, 2008·0 cites·10 claims
- 2152US4911911ARibosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoproteinSANOFI SA·Filed 1986·Granted Mar 27, 1990·5 cites·24 claims
- 2251US7524857B2Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agentsSANOFI AVENTIS·Filed 2002·Granted Apr 28, 2009·0 cites·9 claims
- 2351US2015005253A1Novel combinations for treating acute myeloid leukaemia or chronic myeloid leukaemiaSANOFI SA·Filed 2014·Application pending·0 cites
- 2448US8236811B2Therapeutic use for treating of leukemiaBOURRIE BERNARD·Filed 2009·Granted Aug 7, 2012·0 cites·10 claims
- 2545US5104976ARibosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoproteinSANOFI SA·Filed 1989·Granted Apr 14, 1992·3 cites·10 claims
- 2644US2005209216A1Phenyl-and pyridyl-diazaheterocycles having a tnf-modulating activityBARONI MARCO·Filed 2003·Application pending·0 cites
- 2743US7812165B26-substituted pyridoindolone derivatives, production and therapeutic use thereofSANOFI AVENTIS·Filed 2006·Granted Oct 12, 2010·0 cites·9 claims
- 2843US7326720B2Phenyl- and pyridylpiperidines with TNF activitySANOFI AVENTIS·Filed 2002·Granted Feb 5, 2008·0 cites·36 claims
- 2942US7211578B2Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activitySANOFI AVENTIS·Filed 2002·Granted May 1, 2007·0 cites·47 claims
- 3039US8063061B26-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereofMUNEAUX YVETTE·Filed 2008·Granted Nov 22, 2011·0 cites·27 claims
- 3134US4911912ARibosome-inactivating glycoproteins, modified by oxidation of their osidic units and reduction, and in vivo prolonged-action immunotoxins containing such a glycoproteinSANOFI SA·Filed 1986·Granted Mar 27, 1990·4 cites·22 claims
- 3229US5106956ARibosome-inactivating glycoproteins, modified by oxidation of their osidic units and reduction, and in vivo prolonged-action immunotoxins containing such a glycoproteinSANOFI SA·Filed 1989·Granted Apr 21, 1992·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Bernard Bourrie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →